Navigating the Landscape of EGFR TKI Resistance in EGFR-Mutant NSCLC – Mechanisms and Evolving Treatment Approaches

The authors synthesize molecular mechanisms that underlie resistance to third-generation EGFR tyrosine kinase inhibitors and discuss emerging approaches to pre-empt resistance through early application of combination therapies.